Dr. Philip James Currie
Non-Executive Director
Pharmaceutical
Optiscan Imaging Ltd (OIL.AX)
Australia
Biography
Dr. Philip James Currie, MBBS (Hons), FRACP, MBA, has been Non-Executive Director at Optiscan Imaging Limited since July 17, 2017. He is a cardiologist with more than 35 years in cardiology both in the United States and in Australia with extensive experience in medical research, clinical cardiology and business. He has a medical degree, MBBS (Hons) from Monash University and an MBA from the University of Michigan. He completed his medical residency and cardiology fellowship at the Alfred Hospital in Melbourne before moving to the USA in 1983. At the Mayo Clinic, he completed a cardiology fellowship and then was a Senior Associate Cardiologist. He then was a staff cardiologist for 3 years at the Cleveland Clinic and then to Michigan as the Director of Echocardiography at the Michigan Heart and Vascular Institute for 8 years. During his time in the USA, Philip was involved in the research/pioneering/validation of many of the major advances in echocardiography (including Doppler echo, intra-operative echocardiography and transoesophageal echocardiography) including working closely as a luminary with the major international ultrasound manufacturers. In 1997, after working in the USA for 14 years, Philip returned to Australia and over the last 20 years he has successfully established a private cardiology practice which has subsequently evolved to become an integrated multispecialty medical organisation with 12 sites in Perth and Melbourne.
Research Interest
Clinical Chemistry Analytical Technique Bioanalytical Technique Pharmaceutical Technique